+421.0%
MRNA vs GD
+2.2%
+418.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.3% | -0.6% | +5.9% | +5.2% |
| 7D | +14.6% | -5.0% | +19.6% | +14.2% |
| 30D | +29.4% | +8.9% | +20.4% | +27.1% |
| 3M | +371.9% | -8.0% | +380.0% | +386.1% |
| 6M | +421.0% | +2.9% | +418.1% | +381.3% |
| All | +421.0% | +2.2% | +418.8% | +381.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GD.
Daily Out/Under-Performance
Portfolio return minus GD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling